Latest & greatest articles for type 2 diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on type 2 diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on type 2 diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for type 2 diabetes

161. The effects of a supportive-educational intervention on women with type 2 diabetes and diabetic peripheral neuropathy: a randomized controlled trial

The effects of a supportive-educational intervention on women with type 2 diabetes and diabetic peripheral neuropathy: a randomized controlled trial The Effects of a Supportive-Educational Intervention on Women With Type 2 Diabetes and Diabetic Peripheral Neuropathy: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily (...) Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Clin Rehabil Actions . 2020 Jun;34(6):794-802. doi: 10.1177/0269215520914067. Epub 2020 Apr 20. The Effects of a Supportive-Educational Intervention on Women With Type 2 Diabetes and Diabetic Peripheral Neuropathy: A Randomized Controlled Trial , , , Affiliations Expand Affiliations 1 Bohlool Hospital, Gonabad University of Medical Sciences

2020 EvidenceUpdates

162. A pragmatic study of mid-mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real-world experience Full Text available with Trip Pro

A pragmatic study of mid-mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real-world experience A Pragmatic Study of Mid-Mixture Insulin and Basal Insulin Treatment in Patients With Type 2 Diabetes Uncontrolled With Oral Antihyperglycaemic Medications: A Lesson From Real-World Experience - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set (...) Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Diabetes Obes Metab Actions . 2020 Apr 8. doi: 10.1111/dom.14052. Online ahead of print. A Pragmatic Study of Mid-Mixture Insulin and Basal Insulin Treatment in Patients With Type 2 Diabetes Uncontrolled With Oral Antihyperglycaemic Medications: A Lesson

2020 EvidenceUpdates

163. Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24-week, open-label, controlled trial (STOP-OB) Full Text available with Trip Pro

Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24-week, open-label, controlled trial (STOP-OB) Comparison of Tofogliflozin Versus Glimepiride as the Third Oral Agent Added to Metformin Plus a Dipeptidyl peptidase-4 Inhibitor in Japanese Patients With Type 2 Diabetes: A Randomized, 24-week, Open-Label, Controlled Trial (STOP-OB) - PubMed This site needs (...) to Metformin Plus a Dipeptidyl peptidase-4 Inhibitor in Japanese Patients With Type 2 Diabetes: A Randomized, 24-week, Open-Label, Controlled Trial (STOP-OB) , , , , , , , , , , Affiliations Expand Affiliations 1 Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. 2 Seino Internal Medicine Clinic, Koriyama, Japan. 3 Internal Medicine, Oyama East Clinic, Oyama, Japan. 4 Department

2020 EvidenceUpdates

164. Use of sodium-glucose cotransporter-2 inhibitors and risk of acute kidney injury in older adults with diabetes: a population-based cohort study Full Text available with Trip Pro

Use of sodium-glucose cotransporter-2 inhibitors and risk of acute kidney injury in older adults with diabetes: a population-based cohort study Use of Sodium-Glucose cotransporter-2 Inhibitors and Risk of Acute Kidney Injury in Older Adults With Diabetes: A Population-Based Cohort Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily (...) Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation CMAJ Actions . 2020 Apr 6;192(14):E351-E360. doi: 10.1503/cmaj.191283. Epub 2020 Apr 5. Use of Sodium-Glucose cotransporter-2 Inhibitors and Risk of Acute Kidney Injury in Older Adults With Diabetes: A Population-Based Cohort Study , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Departments of Epidemiology and Biostatistics

2020 EvidenceUpdates

165. Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial Safety and Efficacy of Oral Semaglutide Versus Dulaglutide in Japanese Patients With Type 2 Diabetes (PIONEER 10): An Open-Label, Randomised, Active-Controlled, Phase 3a Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History (...) a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Lancet Diabetes Endocrinol Actions . 2020 May;8(5):392-406. doi: 10.1016/S2213-8587(20)30074-7. Safety and Efficacy of Oral Semaglutide Versus Dulaglutide in Japanese Patients With Type 2 Diabetes (PIONEER 10): An Open-Label, Randomised, Active-Controlled, Phase 3a Trial

2020 EvidenceUpdates

166. Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients With Type 2 Diabetes: Findings From a Population-Based Cohort Study Full Text available with Trip Pro

Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients With Type 2 Diabetes: Findings From a Population-Based Cohort Study Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients With Type 2 Diabetes: Findings From a Population-Based Cohort Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other (...) for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Diabetes Care Actions . 2020 Apr 28;dc192116. doi: 10.2337/dc19-2116. Online ahead of print. Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients With Type 2 Diabetes: Findings From a Population-Based Cohort Study , , , , , , , , , , Affiliations Expand Affiliations

2020 EvidenceUpdates

167. Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study

Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health (...) Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Diabetes Care Actions . 2020 Jul;43(7):1553-1556. doi: 10.2337/dc19-1944. Epub 2020 Apr 28. Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Division of Endocrinology, Department of Pediatrics, The Hospital

2020 EvidenceUpdates

168. Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study Full Text available with Trip Pro

Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study Safety of Dapagliflozin in a Broad Population of Patients With Type 2 Diabetes: Analyses From the DECLARE-TIMI 58 Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National (...) : Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Diabetes Obes Metab Actions . 2020 Apr 2. doi: 10.1111/dom.14041. Online ahead of print. Safety of Dapagliflozin in a Broad Population of Patients With Type 2 Diabetes: Analyses From the DECLARE-TIMI 58 Study , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Diabetes Unit, Department of Endocinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem

2020 EvidenceUpdates

169. ABCD position statement on standards of care for management of adults with type 1 diabetes

ABCD position statement on standards of care for management of adults with type 1 diabetes Standards of Care for Management of Adults with Type 1 Diabetes | ABCD (Diabetes Care) Ltd You are here: Standards of Care for Management of Adults with Type 1 Diabetes 2020 ABCD Standards of care for the management of adults with type 1 diabetes provides comprehensive standards for units providing care to people with type 1 diabetes and is intended as a resource for specialist teams. A summary document (...) is also available which includes a short summary of the recommendations from each section. The sections on inpatient care and management of diabetic emergencies are particularly relevant today. We are grateful to all the contributors. Discipline: Diabetes Clinical taxonomy: Type 1 diabetes mellitus Resource taxonomy: Guidelines Position Paper Information for HCPs Follow Us Address for correspondence: ABCD (Diabetes Care) Ltd, Miria House, 1683b High Street, Knowle, Solihull, West Midlands, B93 0LL

2020 Association of British Clinical Diabetologists

170. Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial Full Text available with Trip Pro

Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial Long-term Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (The DEPICT-2 Study): 52-week Results From a Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search (...) Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Diabetes Obes Metab Actions . 2020 Apr 20. doi: 10.1111/dom.14060. Online ahead of print. Long-term Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (The DEPICT-2 Study): 52-week Results From a Randomized Controlled Trial

2020 EvidenceUpdates

171. Effects of an Electronic Software Prompt With Health Care Professional Training on Cardiovascular and Renal Complications in a Multiethnic Population With Type 2 Diabetes and Microalbuminuria (the GP-Prompt Study): Results of a Pragmatic Cluster-Randomize

Effects of an Electronic Software Prompt With Health Care Professional Training on Cardiovascular and Renal Complications in a Multiethnic Population With Type 2 Diabetes and Microalbuminuria (the GP-Prompt Study): Results of a Pragmatic Cluster-Randomize Effects of an Electronic Software "Prompt" With Health Care Professional Training on Cardiovascular and Renal Complications in a Multiethnic Population With Type 2 Diabetes and Microalbuminuria (The GP-Prompt Study): Results of a Pragmatic (...) Software "Prompt" With Health Care Professional Training on Cardiovascular and Renal Complications in a Multiethnic Population With Type 2 Diabetes and Microalbuminuria (The GP-Prompt Study): Results of a Pragmatic Cluster-Randomized Trial , , , , , , , Affiliations Expand Affiliations 1 Diabetes Research Centre, University of Leicester, Leicester, U.K. 2 National Institute for Health Research Applied Research Collaboration (ARC) East Midlands, Leicester, U.K. 3 George Eliot Hospital National Health

2020 EvidenceUpdates

172. Haematological Indices and Anaemia in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis Full Text available with Trip Pro

Haematological Indices and Anaemia in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis Haematological Indices and Anaemia in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis | SpringerLink Search Search SpringerLink Search Haematological Indices and Anaemia in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis , & volume 2 , pages 899 – 908 ( 2020 ) 454 Accesses Abstract The objective of this paper (...) is to systematically review and meta-analyse the relationship between haematological indices, anaemia and their significance in patients with type 2 diabetes mellitus (T2DM). A search of studies was conducted in the main databases (Medline, PubMed, EMBASE and Google Scholar) and the reference lists of selected studies. Comparative cross-sectional and case-control studies that met the eligibility criteria were included in this meta-analysis. There was no limitation in terms of language. Two independent researchers

2020 SN Comprehensive Clinical Medicine

173. Screening for type 2 diabetes mellitus. (Abstract)

Screening for type 2 diabetes mellitus. Diabetes mellitus, a metabolic disorder characterised by hyperglycaemia and associated with a heavy burden of microvascular and macrovascular complications, frequently remains undiagnosed. Screening of apparently healthy individuals may lead to early detection and treatment of type 2 diabetes mellitus and may prevent or delay the development of related complications.To assess the effects of screening for type 2 diabetes mellitus.We searched CENTRAL (...) % of participants were women; the average age of participants was 58.2 years in the screening group and 57.9 years in the no-screening group. Almost half of participants in both groups were on antihypertensive medication. The findings from the first phase of this study indicate that screening compared to no screening for type 2 diabetes did not show a clear difference in all-cause mortality (hazard ratio (HR) 1.06, 95% confidence interval (CI) 0.90 to 1.25, low-certainty evidence). Screening compared

2020 Cochrane

174. Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis Full Text available with Trip Pro

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer (...) review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Original investigation Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis Elvira D'Andrea, Aaron S. Kesselheim

2020 Research Square

175. Smartphone applications in the prevention of Type 2 Diabetes Mellitus: a protocol for a systematic review Full Text available with Trip Pro

Smartphone applications in the prevention of Type 2 Diabetes Mellitus: a protocol for a systematic review Smartphone applications in the prevention of Type 2 Diabetes Mellitus: a protocol for a systematic review | medRxiv Search for this keyword Smartphone applications in the prevention of Type 2 Diabetes Mellitus: a protocol for a systematic review Esrat Jahan , Rawan Almansour , Kiran Ijaz , Rimante Ronto , Liliana Laranjo doi: https://doi.org/10.1101/2020.05.18.20106211 Esrat Jahan 1 Faculty (...) increasing every day. Studies have shown that it is possible to prevent type 2 diabetes in high risk people if they adopt a healthy lifestyle, such as exercising regularly, eating nutritious food and maintaining an ideal weight. Mobile apps may aid these people in maintaining a healthy lifestyle. Till date, no systematic review has evaluated the use of mobile health applications for the prevention of type 2 diabetes. In this systematic review protocol we will lay out the methods we will use to synthesise

2020 Cold Spring Harbor Laboratory

176. The prevalence of type 2 diabetes in Afghanistan: a systematic review and meta-analysis Full Text available with Trip Pro

The prevalence of type 2 diabetes in Afghanistan: a systematic review and meta-analysis The prevalence of type 2 diabetes in Afghanistan: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This preprint is under consideration at BMC Public Health . A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint (...) on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The prevalence of type 2 diabetes in Afghanistan: a systematic review and meta-analysis Sohail Akhtar, Jamal Abdul Nasir, Amara Javed, Mariyam Saleem, Sundas Sajjad, Momna Khan, Abdul wadood Sohail Akhtar Government College University Lahore Faculty of Science and Technology Corresponding Author ORCiD: https://orcid.org/0000

2020 Research Square

177. Comparative efficacy of GLP-1 RAs and SGLT2 inhibitors for prevention of cardiorenal events in type 2 diabetes: a network meta-analysis of cardiovascular outcome trails Full Text available with Trip Pro

Comparative efficacy of GLP-1 RAs and SGLT2 inhibitors for prevention of cardiorenal events in type 2 diabetes: a network meta-analysis of cardiovascular outcome trails Inplasy Protocol 314 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

178. Metabolic syndrome among type 2 diabetic patients in Sub-Saharan African countries: a systematic review and meta-analysis Full Text available with Trip Pro

Metabolic syndrome among type 2 diabetic patients in Sub-Saharan African countries: a systematic review and meta-analysis Metabolic syndrome among type 2 diabetic patients in Sub-Saharan African countries: a systematic review and meta-analysis | medRxiv Search for this keyword Metabolic syndrome among type 2 diabetic patients in Sub-Saharan African countries: a systematic review and meta-analysis Wondimeneh shibabaw shiferaw , Tadesse Yirga Akalu , Mihretie Gedefaw , Yared Asmare Aynalem (...) Science, College of Medicine and Health Science, Bahir Dar University Address: P.O. Box 79, Bahir Dar, Ethiopia; Email: For correspondence: Abstract Background Metabolic syndrome is one of the serious public health problems among type 2 diabetic patients. Despite a number of studies have been conducted, there is no overall estimation on the prevalence of metabolic syndrome among type 2 diabetic patients in Sub-Saharan African countries. Therefore, this study aimed to estimate the pooled prevalence

2020 Cold Spring Harbor Laboratory

179. The prevalence of type 2 diabetes and prediabetes among armed forces personnel: a systematic review and meta-analysis Full Text available with Trip Pro

The prevalence of type 2 diabetes and prediabetes among armed forces personnel: a systematic review and meta-analysis The prevalence of type 2 diabetes and prediabetes among armed forces personnel: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This preprint is under consideration at BMC Public Health . A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior (...) to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The prevalence of type 2 diabetes and prediabetes among armed forces personnel: a systematic review and meta-analysis Mohammad Fathalipour, Soheil Hassanipour, Mojtaba Sepandi, Maryam Taghdir, Sepideh Abbaszadeh Mohammad Fathalipour Hormozgan University of Medical Sciences

2020 Research Square

180. Following a Low Carbohydrate, High Fat Diet Compared to Reduced Calorie, High Carbohydrate Diet as a Nutritional Intervention in Type Two Diabetes Mellitus Patients: A Systematic Review Full Text available with Trip Pro

Search Search Scope Browse Font Size Information Current Issue > > Following a Low Carbohydrate, High Fat Diet Compared to Reduced Calorie, High Carbohydrate Diet as a Nutritional Intervention in Type Two Diabetes Mellitus Patients: A Systematic Review Joy Lewis, Kevin Haubrick Abstract There is evidence supporting individuals with type 2 diabetes benefit from lifestyle changes through a nutrition intervention that improves diabetic (blood glucose and HgbA1c) and cardiovascular (total cholesterol (...) , HDL, LDL, and triglycerides) biomarkers. The objective of this systematic review was to evaluate if patients with type 2 diabetes following a low carbohydrate, high fat eating pattern is more effective than following a reduced caloric, high carbohydrate eating pattern in the improvement of diabetic (blood glucose and HgbA1c) and cardiovascular (total cholesterol, HDL, LDL, and triglycerides) biomarkers. A literature search was conducted on peer-reviewed research trials registered in PubMed, from

2020 Journal of Food Studies